Back

Treatment patterns and clinical outcomes following diagnosis in patients with ATTR Amyloidosis - Results from the OverTTuRe Study

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in prognosis of heart failure Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Assistant Professor Kevin Alexander

Stanford University School of Medicine, Palo Alto (United States of America)

3 More presentations in this session

Presentation thumbnail
Incidence of heart failure and clinical course of patients with acute myocardial infarction in the modern era of early revascularization in the Asian population
Doctor I. Chung (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Sex-specific associations of serial NT-proBNP with incident heart failure and its subtypes
Mr T. Kok (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Discharge checklists and their impact on GDMT adherence and clinical outcomes in HFrEF patients: a comparative analysis
Ms E. Choi (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in prognosis of heart failure

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Contemporary description of cardiac manifestations in ATTR amyloidosis: results from the multi-country OverTTuRe study
thumbnail
Congress Presentation
Early clinical manifestations and time-to-diagnosis in patients with ATTR amyloidosis with mixed phenotype - results from the OverTTuRe study
thumbnail
Congress Presentation
Clinical presentation and treatment landscape of patients with transthyretin amyloidosis with cardiomyopathy: a real-world study in five European countries and Japan

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources